{
  "drug_name": "Promethazine",
  "url": "https://wikem.org/wiki/Promethazine",
  "scraped_at": "2026-01-10T08:00:39.864406",
  "sections": {
    "Administration": {
      "text": "Type: Antiemetic;\nPhenothiazine\nDerivative; Sedative\nDosage Forms: 12.5mg, 25mg, 50mg; 6.25mg/5 mL sol; IM; IV\nRoutes of Administration: Oral\nCommon Trade Names: Phenadoz; Phenergan; Promethegan",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Phenothiazine",
          "url": "https://wikem.org/wiki/Phenothiazine"
        }
      ]
    },
    "Adult_Dosing": {
      "text": "Allergic conditions\n: 6.25-12.5mg PO tid\nMay give additional dose of 12.5-25mg PO qhs\nNausea/vomiting\n: 12.5-25mg PO/IM/IV q4-6h\nMax: 50mg/dose PO/IM; 25mg/dose IV\nIM preferred over IV\nMotion sickness: 25mg PO bid\nStart: 0.5-1h prior to travel\nSedation: 25-50mg PO/IM/IV x1\nMax: 50mg/dose PO/IM; 25mg/dose IV\nIM preferred over IV",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Allergic conditions",
          "url": "https://wikem.org/wiki/Allergic_conditions"
        },
        {
          "text": "Nausea/vomiting",
          "url": "https://wikem.org/wiki/Nausea/vomiting"
        }
      ]
    },
    "Pediatric_Dosing": {
      "text": "",
      "subsections": {
        "Only_Approved_for_>2_years": {
          "text": "Allergic conditions: 0.1mg/kg PO q6h\nMax: 12.5mg/dose during day, 25mg/dose qhs\nMay give additional dose of up to 0.5mg/kg PO qhs\nUse lowest effective dose\nAvoid other resp. depressants\nNausea/vomiting: 0.25-1mg/kg PO/IM/IV q4-6h PRN;\nMax: 25mg/dose\nMotion sickness: 0.5mg/kg PO q12h PRN; Start: 0.5-1h before travel\nMax: 25mg/dose; Info: use lowest effective dose\nAvoid other resp. depressants\nSedation: 12.5-25mg PO/IM/IV x1\nMax: 25mg/dose\nIM preferred over IV\nUse lowest effective dose\nAvoid other resp. depressants",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Only_Approved_for_>2_years": {
      "text": "Allergic conditions: 0.1mg/kg PO q6h\nMax: 12.5mg/dose during day, 25mg/dose qhs\nMay give additional dose of up to 0.5mg/kg PO qhs\nUse lowest effective dose\nAvoid other resp. depressants\nNausea/vomiting: 0.25-1mg/kg PO/IM/IV q4-6h PRN;\nMax: 25mg/dose\nMotion sickness: 0.5mg/kg PO q12h PRN; Start: 0.5-1h before travel\nMax: 25mg/dose; Info: use lowest effective dose\nAvoid other resp. depressants\nSedation: 12.5-25mg PO/IM/IV x1\nMax: 25mg/dose\nIM preferred over IV\nUse lowest effective dose\nAvoid other resp. depressants",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: C",
      "subsections": {
        "Renal_Dosing": {
          "text": "No adjustment",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "Caution advised with hepatic impairment",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Drug_Ratings_in_Pregnancy"
        }
      ]
    },
    "Renal_Dosing": {
      "text": "No adjustment",
      "subsections": {
        "Hepatic_Dosing": {
          "text": "Caution advised with hepatic impairment",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Hepatic_Dosing": {
      "text": "Caution advised with hepatic impairment",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Contraindications": {
      "text": "Hypersensitivity to drug/component\nPatients <2 yo\nComatose patients\nRespiratory depression\nSC injection\nintra- or periarterial administration",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "extravasation/tissue damage (IV use > IM use)\napnea\nrespiratory depression\nrespiratory depression, fatal (infants)\nseizures\nleukopenia\nthrombocytopenia\nagranulocytosis",
          "tables": []
        },
        "Common": {
          "text": "drowsiness\nsedation\nblurred vision\ndizziness\nconfusion\ndisorientation",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Serious": {
      "text": "extravasation/tissue damage (IV use > IM use)\napnea\nrespiratory depression\nrespiratory depression, fatal (infants)\nseizures\nleukopenia\nthrombocytopenia\nagranulocytosis",
      "subsections": {
        "Common": {
          "text": "drowsiness\nsedation\nblurred vision\ndizziness\nconfusion\ndisorientation",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Common": {
      "text": "drowsiness\nsedation\nblurred vision\ndizziness\nconfusion\ndisorientation",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: 7-14 hrs\nMetabolism: urine, feces\nExcretion: CYP450",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Mechanism_of_Action": {
      "text": "nonselective antagonist of central and peripheral H1 receptors; anticholinergic",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "See_Also": {
      "text": "Antiemetics",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Antiemetics",
          "url": "https://wikem.org/wiki/Antiemetics"
        }
      ]
    },
    "References": {
      "text": "<UpToDate, Micromedex>",
      "subsections": {},
      "tables": [],
      "links": []
    }
  }
}